Abstract--In order to evaluate the potential usefulness of the drug as an anti depressant, acute and chronic effects of rolipram, a selective inhibitor of Cat' and calmodulin-independent cyclic AMP phosphodiesterase were investigated on muricide in olfactory bulbectomized (OB) rats. Upon single administration to OB rats, rolipram at a dosage of 1 mg/kg body weight suppressed the muricide for 2 hr after its administration.
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As a consequence of daily administration of rolipram, however, the incidence of muricide at 24 hr after the administration was decreased, and more than 60% of the rats did not exhibit the muricide on the 12th day. After the cessation of the administration, the incidence of the muricide returned to the initial level. The suppression of the muricide was not antagonized by several kinds of neurotransmitter blockers. Administrations of phosphodiesterase inhibitors and dibutyryl cyclic AMP as well as desipramine and clomipramine also suppressed the muricide dose-dependently.
Repeated administration of desipramine also gave results similar to those of rolipram: repetition of a short suppression on the muricide was followed by the appearance of a long-lasting suppression.
Differently from rolipram and desipramine, dibutyryl cyclic AMP did not cause long-lasting sup pression, and even the direct effect (75% suppression) observed 30 min after its administration on the first day disappeared during its repeated administration for 14 days.
From these results, rolipram was considered to show an antidepressant effect through the inhibition of Cat+ and calmodulin-independent cyclic AMP phosphodiesterase.
Rolipram is a novel dialkoxyphenyl pyr rolidone derivative (Fig. 1 ) that was shown to inhibit Cat' and calmodulin-independent cyclic AMP phosphodiesterase (PDE) activity in vitro (1 ), causing an increase in the cyclic AMP content of discrete regions of rat brain in vivo (2). Based on its ability to reverse reserpine-induced hypothermia or hypoki nesia, to potentiate yohimbine toxicity and to reduce the immobility time in a forced swimming test (3-6), rolipram is expected to possess antidepressant activity. Since rolipram was reported neither to have an anti cholinergic effect nor to inhibit monoamine oxidase activity and monoamine reuptake (4), rolipram may be a new type of drug, which differs from the tricyclic antidepressants. Method: Male Wistar rats (Clea Japan, Inc.) weighing 180 to 220 g at the time of surgery were used. Three weeks after bilateral olfactory bulbectomy, which was performed as previously described (11), only rats exhibit ing muricide were used; 5 to 60% of olfactory bulbectomized (OB) rats displayed muricide under our conditions. Throughout the experiment, each rat was kept in an isolated cage at a temperature of 22±2'C with a 12 hr light-dark cycle and allowed free access to food and water.
Muricide was tested before and at various times after intraperitoneal administration of drugs, unless otherwise mentioned, and was assessed as positive if the rat killed a mouse within 3 min after introducing the mouse into the rat's homecage. The injection volume of drug solution was fixed at 0.1 nil per 100 g body weight.
Statistical analysis was done by Fisher's exact probability test.
Results
Effect of single administration of rolipram on muricide: The effect of a single adminis tration of 1 mg rolipram/kg body weight on the muricide was compared with those of 10 mg desipramine/kg body weight and 20 mg clomipramine/kg body weight (Fig. 2) . These drugs suppressed the muricide 30 min after their administration. Rolipram suppressed it most effectively among the three drugs under this condition. However the antimuricide activity of rolipram disappeared within 2 hr, while those of clomipramine and desipramine lasted for a longer period of 4 to 6 hr. The effect of rolipram at 30 min after adminis tration at dosages of 0.1 to 10 mg/kg body weight was found to be dose-dependent with an ED50 of 0.4 mg/kg body weight. Of the isomers of rolipram, the (-)-isomer suppressed the muricide markedly but the (+)-isomer did not at a dosage of 1 mg/kg body weight (Table 1) . Although mild sedation of OB rats was observed after administration of these drugs at the dosages effectively suppressing the muricide, neither muscle relaxation nor ataxia appeared.
Possible involvement of a neurotransmitter in the effect of rolipram: The antimuricide effect of rolipram was not blocked by pretreat ment of the rat with subcutaneous adminis tration of phenoxybenzamine at a dosage of 20 mg/kg body weight, which is known to inhibit the antimuricide effect of desipramine ( Table 2) . None of the other antagonists such as propranolol (10 mg/kg body weight, s.c.), methysergide (2 mg/kg body weight, i.p.), bicuculline (3 mg/kg body weight, i.p.) and theophylline (25 mg/kg body weight, i.p.) blocked the antimuricide activity of rolipram. At the dosage used, these antagonists did not affect the muricide by themselves. at a dosage of 10 mg/ kg body weight, theophylline at 100 mg/kg body weight and papaverine at 40 mg/kg body weight, although the required dosages were rather high as compared to that of rolipram (Table 1) . The rats treated with these PDE inhibitors showed mild sedation, but no muscle relaxation and ataxia.
These results prompted us to examine whether cyclic AMP suppresses the muricide. As shown in Fig. 3 , 50 to 200 mg/kg body weight of Bt2 cAMP, a membrane penetrat ing analog of cyclic AMP, suppressed the muricide dose-dependently 30 min after intraperitoneal administration. The anti muricide effect of Bt2 cAM P disappeared rather quickly; muricide was restored in the rats at 1, 2 and 4 hr after the administration at dosages of 50, 100 and 200 mg/kg body weight, respectively. Administration of Bt2 cAM P caused marked sedation. Effect of repeated administration of drugs on muricide: In order to assess wether there is a long-lasting effect with repeated admin istration, the incidence of the muricide was tested 24 hr after daily administration of the drug. As shown in Fig. 4 , the incidence of the muricide in daily administration of rolipram was decreased dose and time dependently.
With a dosage of 0.35 mg/kg body weight, the incidence began to decrease from day 7 and reached about 50% at day 14. With 1 or 3 mg/kg body weight, the decreases were much quicker and greater than with 0.35 mg/kg body weight; the incidence began to decrease within a few days and almost complete inhibition of the muricide was already attained by day 7. It should be noted that neither noticeable sedation nor ataxia and muscle relaxation were observed at the testing time.
With a dosage of 1 mg rolipram/kg body weight, the suppressive effect on the muricide which was tested 30 min after administration was apparent already at the 1st day and tended to be strengthened day by day (Fig. 5) . After the daily drug adminis tration was terminated, muricide was restored in the rats within about one week.
Similar results were observed with the repeated administration of desipramine at a dosage of 10 mg/kg body weight (Fig. 5) : progressive potentiation of the suppressive activity tested 1 hr after the drug administra tion and gradual appearance of a long lasting suppression effect.
The repeated administration of Bt2 cAMP at a dosage of 100 mg/kg body weight for 15 days did not cause a long-lasting suppressive effect on the muricide (Fig. 6) , and even the suppressive effect on the muricide tested 30 min after the administration (about 75% on the first day) disappeared gradually during the daily administration.
The sedative effect observed also disappeared gradually. It was re ported that the antimuricide effect of desipra mine is antagonized by phenoxybenzamine but unaffected by sotalol and propranolol (10, 12), indicating that the effect of tricyclic anti-depressants results from an activation of the mechanism mediated via a-adrenergic receptor. In contrast to the effect of desipra mine, the antimuricide effect of rolipram was prevented by none of the blockers for a and Q-adrenergic, serotonin, GABA and adenosine receptors. Taking these results together with the finding that rolipram did not possess any binding ability to various types of neuro transmitter receptors in rat brain (13), it is considered that the effect of rolipram is not ascribable to a direct effect on neurotrans mitters such as those of typical antidepres sants which increase the availability of monoamines in the synaptic cleft. Therefore, the antimuricide effect of rolipram probably results from either a direct or indirect effect which is derived from an increased level of cyclic AM P caused by the inhibitory action on brain cyclic AMP PDE. This consideration is supported by the following lines of evidence. First, suppression of the muricide was induced by (-)-rolipram but not by its (+) isomer, the former being the isomer re sponsible for the inhibition of Cat' and Open circles indicate the muricide test before injection of drugs. Closed circles indicate the muricide test 30 min and 1 hr after injection of (±)-rolipram and desipramine, respectively.
Repeated administration was conducted once daily for 1 2 days between the arrow (T) and double arrows (TT). Eight animals were used in each experiment.
calmodulin-independent cyclic AMP PDE (14). In several kinds of behavior tests in animals, (-)-rolipram was also shown to be the active component of (±)-rolipram (4, 15). For instance, in the reserpine antagonism and the yohimbine potentiation tests, the (+) isomer was only 1/10 to 1/15 as potent as the (-)-isomer (4). Similar results were also observed in a drug descrimination test (16, 17) . Secondly, Ro 20-1724, which is known to be a specific inhibitor of Ca2+ and CaM independent cyclic AMP PDE like rolipram (1), was able to suppress the muricide. The relative potency of the antimuricide activity of rolipram and Ro 20-1724 appears to be proportional to the potency of inhibitory action on PDE activity in vitro (1 ). For other PDE inhibitors at higher dosages, again there seems to be a correlation between their potencies in these two activities (1). Thirdly, a single administration of Bt2cAMP sup pressed the muricide dose-dependently as rolipram did, and rolipram has been reported to increase cyclic AMP levels in particular regions of the brain such as the frontal cortex and striatum of the rat in vivo (2).
on OB rats via a noradrenergic mechanism, it may be concluded from these lines of evidence that the effect of rolipram on the muricide is ascribable to an increase of cyclic AMP level in a neural pathway in which the noradrenergic mechanism also participates. The fact that not only desipramine but also rolipram caused a long-lasting effect on the muricide, therefore, further indicates that rather than those at the receptor site, altera tions in the post-receptor site may be a common mechanism for a long-lasting sup pression of the muricide.
